These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of long-term calcitonin therapy by injection and nasal spray on the incidence of fractures in osteogenesis imperfecta. Nishi Y, Hamamoto K, Kajiyama M, Ono H, Kihara M, Jinno K. J Pediatr; 1992 Sep; 121(3):477-80. PubMed ID: 1517930 [Abstract] [Full Text] [Related]
10. Lack of effects of human calcitonin in osteogenesis imperfecta. Pedersen U, Charles P, Hansen HH, Elbrønd O. Acta Orthop Scand; 1985 Jun; 56(3):260-4. PubMed ID: 4036580 [Abstract] [Full Text] [Related]
17. Are drugs helpful in adults with osteogenesis imperfecta? Chevrel G, Meunier PJ. Rev Rhum Engl Ed; 1997 May; 64(5):283-6. PubMed ID: 9190000 [No Abstract] [Full Text] [Related]
18. Vitamin D and cyclic nucleotide changes in response to calcitonin in man. Nishi Y, Hyodo S, Usui T, Seino Y, Yamaoka K. Hiroshima J Med Sci; 1985 Sep; 34(3):277-80. PubMed ID: 2999043 [No Abstract] [Full Text] [Related]
19. Medical management of osteogenesis imperfecta [proceedings]. Paterson CR. Scott Med J; 1977 Jan; 22(1):87-8. PubMed ID: 836580 [No Abstract] [Full Text] [Related]
20. Vitamin D and related research in osteogenesis imperfecta. Sbyrakis S, Mengreli C, Côté GB, Morakis A. Prog Clin Biol Res; 1982 Jan; 104():367-76. PubMed ID: 6298814 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]